Sales of foreign-invested pharmaceutical firms up 14.6%
Published: 2008-04-24 07:00:00
Updated: 2008-04-24 07:00:00
The combined sales of the 22 major foreign drug makers last year marked a growth rate of 14.6 percent, to 3.2 trillion won from 2006, according to data analyzed by Yakup Shinmoon. Their operating income showed an average increase of 6.8 percent.
By sales, Pfizer Korea topped the list with 396....
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
